Radiation-induced Pulmonary Fibrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-05-02
Clinical Trial Update: Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer [NA]
The clinical trial evaluating losartan for pulmonary fibrosis in patients with stage I–III non-small cell lung cancer has been withdrawn.